Cancer Control Research: OCS Analysis for FY 2001
Overview of the Fiscal Year (FY) 2001 National Institutes of Health (NIH) Cancer Survivorship Research Grant Portfolio
- For this portfolio analysis, survivorship research was defined as that which focused on the health and life of a person with a history of cancer beyond the acute diagnosis and treatment phase.
- Studies that examined newly diagnosed survivors or those in active treatment were included in the portfolio analysis if follow-up extended at least two months or longer post-treatment
- Studies addressing recurrence or end-of-life research were not included in this particular analysis.
Chart 1 shows the distribution of the FY2001 survivorship research grant portfolio by federal government organization: The National Cancer Institute (NCI), and Other National Institutes of Health.
Chart 2 shows the distribution of FY 2001 survivorship research grants by cancer site. Approximately 33% of NIH survivorship research grants have a primary focus on female breast cancer survivors. Of these, over half (51% or N = 24) examine the efficacy of a physiologic, psychosocial or health behavior intervention for breast cancer survivors.
Table 1 shows the distribution of FY2001 survivorship research grants by focus and funding levels: physiologic, psychosocial, or health behavior interventions, psychosocial/physiologic sequelae, patterns & quality of care, surveillance, and training and conference grants.
Table 2 shows the distribution of FY2001 survivorship research grants that focus on the family members of cancer survivors: spouses, parents, children (both young, and adult), caregivers, and the family unit as a whole.
NIH Breakout of FY 2001 Survivorship Research
Grants: by Federal Government Organization (N=142)
NIH Survivorship Research Portfolio by Site (N=142)